The FDA has sent warning letters to 13 molecular diagnostic companies as part of its bid to improve the regulation of genetic testing. The agency has targeted firms selling genetic tests directly to consumers, including Interleukin Health, CyGene Direct and Consumer Genetics. It also ...
Please Login to read the full article.
